期刊文献+

三种粗粮粉体外调节肠道菌群的作用研究 被引量:3

In vitro regulation effect of three kinds of bran-rich cereal flour on intestinal microbiota
下载PDF
导出
摘要 通过在体外模拟构建消化和发酵体系,研究不同来源的三种麸皮(小麦麸皮、黑小麦麸皮和燕麦麸皮)配制成的粗粮粉对肠道菌群调节作用的影响。采用高通量测序技术16S rRNA 对肠道菌群的多样性和组成进行分析,结果表明,粗粮粉发酵后微生物多样性降低,肠道菌群组成发生了较大变化,拟杆菌门比例下降,厚壁菌门比例升高,代谢产生的短链脂肪酸含量显著增多(p<0.05);其中,燕麦粗粮粉促进双歧杆菌体外增殖的效果优于其他两组粗粮粉,分别是小麦粗粮粉和黑小麦粗粮粉的1.45和2.14倍。本研究为调制加工性能好、保健价值高的粗粮粉配方提供了理论依据。 The effects of three kinds of bran-rich cereal flour( wheat bran, rye wheat bran and oat bran)on the regulation of intestinal flora were studied by constructing simulated digestion and fermentation system in vitro.The diversity and composition of intestinal flora were analyzed by high throughput sequencing 16S rRNA. The results showed that the a-diversity of gut microbiota was decreased,the composition of intestinal microflora was significantly change, the diversity and the proportion of Bacteroidetes was decreased, the proportion of Firmicutes was increased, and the content of short-chain fatty acids produced by metabolism increased significantly (p 〈 0.05 ).The effect of oat-rich cereal flour on the proliferation of Bifidobacterium in vitro was significantly higher than the other two groups, which was 1.45 and 2.14 times of wheat-rich cereal flour and rye-rich cereal flour respectively. This study provides a theoretical basis for the preparation of bran- rich cereal flour with good processing performance and high health care value.
作者 曹文燕 黄莲燕 朱红广 丁立 王静 CAO Wen-yan, HUANG Lian-yan, ZHU Hong-guang, DING Li, WANG Jing(Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Higher Institution Engineering Research Center of Food Additives and Ingredients,geijing Technology and Business University,Beijing 100048, Chin)
机构地区 北京工商大学
出处 《食品工业科技》 CAS CSCD 北大核心 2018年第6期54-58,70,共6页 Science and Technology of Food Industry
基金 国家自然科学基金(31501480,31571940) 北京市优秀人才培育资助青年拔尖团队项目 2017研究生科研能力提升项目.
关键词 粗粮粉 肠道菌群 短链脂肪酸 bran-rich cereal flour intestinal microbiota short-chain fatty acids
  • 相关文献

参考文献5

二级参考文献81

  • 1周景欣,袁杰利,迟俐,张新星.双歧杆菌低聚果糖制剂对便秘人群肠道菌群的调整作用[J].中国微生态学杂志,2006,18(5):399-400. 被引量:30
  • 2郑丽华,贾兰斯.治疗便秘药物的合理选择[J].中国临床医生杂志,2007,35(4):62-63. 被引量:16
  • 3四川恒泰医药有限公司.便秘的药物与治疗进展[C]//四川恒泰医药有限公司,中国中医肛肠教育研讨会暨第十二届中日大肠肛门病学术交流会论文集.成都,2008.
  • 4蒙君.益生菌组合和合生元治疗Wistar大鼠便秘型IBS模板探讨[D].长沙:中南大学,2007.
  • 5QUIGLEY E M M. The enteric microbiota in the pathogenesis and management of constipation[J]. The Journal of Pediatrics, Best Practice & Research Clinical Gastroenterology, 2011, 25(1): 119-126.
  • 6CHEN Hsiaoling, LU Yuho, LIN Jiun, Jr, et al. Effects of fructooligosaccharide on bowel function and indicators of nutritional status in constipated elderly men[J]. Nutrition Research, 2000, 20(12): 1725-1733.
  • 7WINTOLA O A, SUNMONU T O, AFOLAYAN A J. The effect of Aloeferox Mill. in the treatment of loperamide-induced constipation in Wistar rats[J]. BMC Gastroenterology, 2010, 11(1): 95-96.
  • 8HUGHES S, HIGGS N B, TURNBERG L A. Loperamide has antisecretory activity in the human jejunum in vivo[J]. Gut, 1984, 25(9): 931-935.
  • 9SOHJI Y, KAWASHIMA K, SHIMIZU M. Pharmacological studies of loperamide, an anti-diarrheal agent[J]. Folia Pharmacol Japanese, 1978, 74(1): 155-163.
  • 10Pace NR.Problems with “Procaryote ”.Journal ofBacteriology,2009,191(7):2008-2010.

共引文献243

同被引文献48

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部